首页> Asia-Pacific journal of oncology nursing> Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Matthew D,Biniakewitz

第一单位： Clinical Trials Nursing, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

作者： Matthew D,Biniakewitz ^[1] ; Mary Kate,Kasler ^[2] ; Kristen L,Fessele ^[3]

作者单位： Clinical Trials Nursing, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[1] Advanced Practice Providers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[2] Office of Nursing Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[3]

关键词 Aging ipilimumab melanoma nivolumab pembrolizumab symptom assessment

DOI 10.4103/apjon.apjon_48_20

PMID 33426185

发布时间 2022-04-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Asia-Pacific journal of oncology nursing

18-24页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Asia-Pacific journal of oncology nursing

18-24页

检索历史清除

Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

Asia-Pacific journal of oncology nursing

相似文献

同项目论文

Asia-Pacific journal of oncology nursing

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

Asia-Pacific journal of oncology nursing

相似文献

同项目论文

Asia-Pacific journal of oncology nursing

相关期刊

检索历史清除